loading

Pipeline

HK-660S
symptoms in psc

<Symptoms in PSC>

HK-660S

·Target: NADH:quinone oxidoreductase 1 (NQO1)
·Developmental stage: Phase 2 clinical trial in progress
·Indication: Primary Sclerosing Cholangitis (PSC)
PSC is a chronic cholestatic liver disease characterized by inflammation and fibrosis both intra and extrahepatic bile ducts, leading to the formation of multi-focal bile duct strictures, which can lead to liver cirrhosis and liver cancer. Because There is no approved fundamental treatment to date, PSC is a disease with large unmet medical needs.